This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
Remote / online
SchizophreniaBehavioralFrom 15 Years to 24 Years
Countries
United States
Sponsor
John Jay College of Criminal Justice, City University of New York
This study is looking at understand how RR-HNK works in the brain to bring about a reduction in OCD symptoms for people with OCD. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
In United States
OCDDrugA study involving a medication or substance.From 18 Years to 65 Years
This study is looking at whether Ketamine only can help people with depression. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at whether a digital support tool can help people with Parkinson's Disease Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Standard REP included the initial Implementation phase of Re-Engage, specifically: 1 can help people with Serious mental illnesses including schizophrenia, bipolarity, and schizoaffective disorder, Mental and Behavioural Disorders, or Schizophrenia, Bipolarity. Participants take part in Standard REP included the initial Implementation phase of Re-Engage, specifically: 1 and complete follow-up assessments.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.